%201.png){kind=logo}
%202.png){kind=logo}
Cancer Support Community (CSC) has teamed up with EO Care, a leader in clinically guided cannabis health solutions, to provide cancer patients, survivors, and their caregivers with comprehensive support.
With 40% of cancer patients already turning to cannabis for symptom relief, this partnership offers CSC members access to educational materials and personalized guidance on cannabis to ensure its safe and effective use. Led by Dr. Brooke Worster, Director of Supportive Oncology at Jefferson Health and Chief Medical Officer at EO, our specialized expertise ensures that cancer patients receive accurate, personalized information and support through CSC's resources and helpline. This collaboration reflects a crucial step in empowering all those impacted by cancer to make informed decisions about their healthcare journey, providing them with the tools and support needed to navigate their treatment with confidence.
A major policy shift is reshaping how providers and payers approach symptom management. Here’s what cannabis rescheduling means for clinical care, reimbursement, and patient outcomes.
EO Care has appointed healthcare leaders William Fleming (former Humana executive) and Kristi Savacool (former Aon Hewitt CEO) to its Board of Directors, strengthening governance as cannabinoid-based symptom management enters mainstream healthcare.
The Administration’s decision to move to reclassify cannabis from Schedule I to Schedule III is a watershed moment for adult Americans who currently or might benefit from the responsible use of cannabinoids, especially oncology patients and older adults. It’s a long overdue step that will reduce stigma, open doors for essential research and product development, and increase access to care for patients.
Get special offers, event invites and the latest on new care offerings and product releases.
Wise Use for All
© 2026 All rights reserved. Patents pending. EO Care, Inc.
